Gitelman and Bartter patients have higher expression of ACE2 and Ang 1–7, which is also an effect of ACE inhibitors/Angiotensin II receptor blockers, thus supporting the RASi protective effect in SARS-CoV-2 infection in patients with hypertension or diabetes [7,11]. The gene discussed is ACE2; the disease is Hypertension.